English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

A fine-tuned azobenzene for enhanced photopharmacology in vivo

MPS-Authors
/persons/resource/persons244947

Mathes,  Bettina
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons267999

Yarotski,  Dzianis
Chemical Biology, Max Planck Institute for Medical Research, Max Planck Society;

External Resource
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Gutzeit, V. A., Acosta-Ruiz, A., Munguba, H., Häfner, S., Landra-Willm, A., Mathes, B., et al. (2021). A fine-tuned azobenzene for enhanced photopharmacology in vivo. Cell Chemical Biology, 28(11), 1648-1663. doi:10.1016/j.chembiol.2021.02.020.


Cite as: https://hdl.handle.net/21.11116/0000-0009-A23A-F
Abstract
Despite the power of photopharmacology for interrogating signaling proteins, many photopharmacological systems are limited by their efficiency, speed, or spectral properties. Here, we screen a library of azobenzene photoswitches and identify a urea-substituted "azobenzene-400" core that offers bistable switching between cis and trans with improved kinetics, light sensitivity, and a red-shift. We then focus on the metabotropic glutamate receptors (mGluRs), neuromodulatory receptors that are major pharmacological targets. Synthesis of "BGAG12,400," a photoswitchable orthogonal, remotely tethered ligand (PORTL), enables highly efficient, rapid optical agonism following conjugation to SNAP-tagged mGluR2 and permits robust optical control of mGluR1 and mGluR5 signaling. We then produce fluorophore-conjugated branched PORTLs to enable dual imaging and manipulation of mGluRs and highlight their power in ex vivo slice and in vivo behavioral experiments in the mouse prefrontal cortex. Finally, we demonstrate the generalizability of our strategy by developing an improved soluble, photoswitchable pore blocker for potassium channels.